6/11/2014 6:41:13 AM
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it will present at two upcoming investor conferences.
Scheduled presentations include the following:
Wells Fargo 2014 Healthcare Conference – Boston
Help employers find you! Check out all the jobs and post your resume.
comments powered by